Trevor Martin is founder & CEO of Mammoth Biosciences. Mammoth is building the platform for CRISPR applications of the future. They currently have technologies built for diagnostics, genome editing, and protein discovery.
CRISPR is a novel system that enables geneticists and medical researchers to edit parts of the genome by removing, adding or altering sections of the DNA sequence. Trevor joins the show to discuss real applications of this technology. He highlights the speed with which CRISPR has rivaled decades old technologies to diagnose COVID, despite being a much more nascent technology. He shares his excitement for other near-future applications to combat genetic disease. We also chat about the line between fantasy and reality - what kinds of CRISPR applications are too far towards science fiction, and which are grounded in reality.
To learn more about Mammoth, visit https://mammoth.bio/